Smithkline Beecham Corp. v. King Drug Co. of Florence, Inc., 137 S. Ct. 446 (2016). · Go Syfert
Search
Smithkline Beecham Corp. v. King Drug Co. of Florence, Inc., 137 S. Ct. 446 (2016). Cases Citing This Book View Copy Cite
5 citation events (5 in the last 25 years) across 3 distinct courts.
Strongest positive: Boevers v. Coffman (ca10, 2016-12-12)
Top citers, strongest first. 1 distinct citer. How cited ↗
cited Cited "see" Boevers v. Coffman
10th Cir. · 2016 · signal: see · confidence high
See Schell v. OXY USA Inc., 814 F.3d 1107 , 1117 & n.5 (10th Cir. 2016), cert. denied, (U.S. Oct. 31, 2016), and - U.S. -, 137 S.Ct. 446 , 196 L.Ed.2d 328 , 2016 WL 4001288 (2016).
Retrieving the full opinion text from the archive…
SMITHKLINE BEECHAM CORPORATION, dba GlaxoSmithKline
v.
KING DRUG COMPANY OF FLORENCE, INC.
No. 15–1055..
Supreme Court of the United States.
Nov 7, 2016.
137 S. Ct. 446
Published
1 passage pin-cited by 1 case
Pinpoint authority: bottom 63%
Citer courts: N.D. Illinois (1)

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.